<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Reactive oxygen species (ROS) play key roles in the cascade of brain injury after <z:hpo ids='HP_0001297'>stroke</z:hpo>, and strategies to increase the <z:chebi fb="11" ids="22586">antioxidant</z:chebi> defenses of neurons after <z:hpo ids='HP_0001297'>stroke</z:hpo> hold great promise </plain></SENT>
<SENT sid="1" pm="."><plain>In this study we evaluate the neuroprotective potential of using a <z:e sem="disease" ids="C0019348" disease_type="Disease or Syndrome" abbrv="">herpes simplex</z:e> <z:mp ids='MP_0001799'>viral</z:mp> vector to over-express catalase in rats </plain></SENT>
<SENT sid="2" pm="."><plain>Vector was microinfused into the striatum either prior to or after middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (MCAO) </plain></SENT>
<SENT sid="3" pm="."><plain>Catalase over-expression was protective (relative to control vector) when the vector was delivered 14-16 h prior to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>, but not when delivered after <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> </plain></SENT>
<SENT sid="4" pm="."><plain>Thus, the timing of catalase over-expression relative to <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> is a critical variable determining its potential therapeutic value </plain></SENT>
</text></document>